Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn, AD Norden… - Neuro …, 2009 - academic.oup.com
Platelet-derived growth factor (PDGF) and its receptors (PDGFR) are frequently coexpressed
in meningiomas, potentially contributing to their pathogenesis. The North American Brain …
被引用次数：179 相关文章
[PDF] researchgate.net

[PDF][PDF] Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn, AD Norden… - Neuro …, 2009 - researchgate.net
Address correspondence to Patrick Y. Wen, Center for Neuro-Oncology, Dana-
Farber/Brigham and Women's Cancer Center, SW430D, 44 Binney St., Boston, MA 02115 …

[引用][C] Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn, AD Norden… - Neuro-Oncology, 2009 - cir.nii.ac.jp
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor
Consortium study 01-08) | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[PDF] academia.edu

[PDF][PDF] Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn, AD Norden… - NEURO …, 2009 - academia.edu
Address correspondence to Patrick Y. Wen, Center for Neuro-Oncology, Dana-
Farber/Brigham and Women's Cancer Center, SW430D, 44 Binney St., Boston, MA 02115 …
[HTML] nih.gov

[HTML][HTML] Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01–08)

PY Wen, WKA Yung, KR Lamborn, AD Norden… - Neuro …, 2009 - ncbi.nlm.nih.gov
Platelet-derived growth factor (PDGF) and its receptors (PDGFR) are frequently coexpressed
in meningiomas, potentially contributing to their pathogenesis. The North American Brain …

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn… - Neuro …, 2009 - pubmed.ncbi.nlm.nih.gov
Platelet-derived growth factor (PDGF) and its receptors (PDGFR) are frequently coexpressed
in meningiomas, potentially contributing to their pathogenesis. The North American Brain …

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn… - Neuro …, 2009 - providence.elsevierpure.com
Platelet-derived growth factor (PDGF) and its receptors (PDGFR) are frequently coexpressed
in meningiomas, potentially contributing to their pathogenesis. The North American Brain …

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn… - Neuro …, 2009 - mdanderson.elsevierpure.com
Platelet-derived growth factor (PDGF) and its receptors (PDGFR) are frequently coexpressed
in meningiomas, potentially contributing to their pathogenesis. The North American Brain …

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

PY Wen, WK Yung, KR Lamborn, AD Norden… - Neuro …, 2009 - europepmc.org
Platelet-derived growth factor (PDGF) and its receptors (PDGFR) are frequently coexpressed
in meningiomas, potentially contributing to their pathogenesis. The North American Brain …
[PDF] researchgate.net

[PDF][PDF] Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

PY Wen, WKA Yung, KR Lamborn, AD Norden… - Neuro …, 2009 - researchgate.net
Address correspondence to Patrick Y. Wen, Center for Neuro-Oncology, Dana-
Farber/Brigham and Women's Cancer Center, SW430D, 44 Binney St., Boston, MA 02115 …